HHS Passes Clinical Trial Reporting Authority To FDA
The U.S. Department of Health and Human Services is delegating some authority over clinical trial reporting and monitoring to the U.S. Food and Drug Administration, according to a notice published Wednesday...To view the full article, register now.
Already a subscriber? Click here to view full article